| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 07/21/2005 | US20050159604 Asymmetric hydrogenation of alpha-amino carbonyl compounds |
| 07/21/2005 | US20050159490 Increasing mean cardiac output without materially increasing heart rate utilizing thyroid hormone analog |
| 07/21/2005 | US20050159487 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 07/21/2005 | US20050159393 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 07/21/2005 | US20050159305 Catalyst for dehydrogenating primary alcohols |
| 07/21/2005 | US20050158374 Compositions and dosage forms for enhanced absorption of metformin |
| 07/20/2005 | EP1554257A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/20/2005 | EP1554242A1 Watersoluble prodrugs of propofol |
| 07/20/2005 | EP1554235A2 Process for synthesizing l-y-methylene glutamic acid and analogs |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | CN1642937A Process for making chiral 1, 4-disubstituted piperazines |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642899A Methods for producing substituted acrylic acid esters and use of the latter for producing substituted dollar G(G)-amino acids |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1211350C In-situ preparation of polyaspartic ester mixture |
| 07/19/2005 | US6919475 A chemical intermediate for use in positron emission tomography, radioactive fluoride compounds with long half life |
| 07/19/2005 | US6919421 End-capping polymerization of aspartic acid, or sodium aspartate in a solvent of supercritical fluid to form polysuccinimide, or polyamideimide copolymer; as fillers for a plastic moldings |
| 07/19/2005 | US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis |
| 07/14/2005 | WO2005063707A1 Enantiospecific process for the preparation of paroxetine intermediate |
| 07/14/2005 | WO2005044779A3 Process for the preparation of gabapentin |
| 07/14/2005 | US20050154221 Having an unsaturated fatty acid or fatty ester; metathesis of the feedstock with a lower olefin; the resulting vinyl ester monomer may be epoxidized, hydroformylated or reductively aminated before oligomerization or polymerization to produce omega-epoxy, hydroxy, or amino vinyl esters |
| 07/14/2005 | US20050154057 Crystalline form of y-aminobutyric acid analog |
| 07/14/2005 | US20050153363 Polymer arrays |
| 07/14/2005 | US20050153362 Polymer arrays |
| 07/13/2005 | EP1551793A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 07/13/2005 | EP1551654A1 A vehicle and a vehicle door |
| 07/13/2005 | EP1551495A2 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| 07/13/2005 | EP1551291A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/13/2005 | EP1020426B1 Amine derivatives and process for producing the same |
| 07/13/2005 | CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 07/13/2005 | CN1636968A Prepn process of N, N-dimethyl glycine (E)-3, 7-dimethyl-2, 6-octadiane |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1210253C Asymmetric synthesis (S)-(+)-3-(aminomethyl)-5-methylhexanoic |
| 07/13/2005 | CN1210252C Process for the preparation of 4-carboxy-5,8,11-tris (carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridencan-13-oic acid |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916947 Forming 8-aminooctanoic acid hydrochloride by reacting halogenated carboxylic acid ester with metal cyanate and alcohol, then saponifying |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916461 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 07/12/2005 | CA2244912C Novel substituted cyclic amino acids as pharmaceutical agents |
| 07/12/2005 | CA2237218C Amino acid analogs for tumor imaging |
| 07/07/2005 | WO2005061433A2 Aminoalcohol derivatives |
| 07/07/2005 | WO2005060569A2 Tame based chelators and uses thereof |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | US20050148792 Process for the preparation of gabapentin |
| 07/07/2005 | US20050148670 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 07/07/2005 | US20050148473 Substituted sulfonylaminomethylbenzoic acid ( derivatives) and their preparation |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050147563 Imaging lymph nodes with a Gadolinium complex of 10-[2-hydroxy-4-aza-5-oxo-7-aza-7-(perfluorooctylsulfonyl)-nonyl]-1,4,7-tris (carboxymethyl)-1,4,7,10-tetraazacyclododecane; in vivo contrast media in nuclear spin tomography; blood-pool agents, lymphographic agents |
| 07/07/2005 | DE10357301A1 Verbindungen zur Modulation des Glykolyse-Enzym- und/oder Transaminase-Komplexes Compounds for modulation of the glycolytic enzyme and / or transaminase complex |
| 07/06/2005 | EP1549598A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN2707358Y Electrodialysis desalination apparatus for glycine solution |
| 07/06/2005 | CN1634872A Method for preparing glycine iron(óÄ) chelate for fortified food |
| 07/06/2005 | CN1634871A Industrial preparation method for 3-amino phenylacetic acid |
| 07/06/2005 | CN1634870A Process for synthesizing carnitine |
| 07/06/2005 | CN1634869A Novel pregabalin crystalline form and its preparing process |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209344C Method for purifying amino acetic acid by electrodialytic separation |
| 07/05/2005 | US6914137 Adjustment of pH |
| 06/30/2005 | WO2005059037A1 Reagent for detecting an analyte |
| 06/30/2005 | WO2005058799A1 Di (l) - lysine monosulfate trihydrate crystal and method of making |
| 06/30/2005 | WO2005058798A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 06/30/2005 | WO2005058797A1 Process for the purification of gabapentin |
| 06/30/2005 | WO2005058269A1 Merocyanine derivatives for cosmetic use |
| 06/30/2005 | US20050143586 N-(di)nitrobenzenesulfonyl-protected-aziridine-2-carboxylic acid derivatives and intermediates; their preparation from haloalanine derivatives that may be N-(di)nitrobenzenesulfonyl-protected, preferably using metal 3,3-dimethyl-3-(optionally protected-amino)propynylides |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050142156 Mono- or di-C-substituted diketopiperazines, e.g., the diketopiperazine of L-Glutamic Acid, are carriers for drug delivery of a wide variety of drugs including biodrugs; oral dosage forms |
| 06/30/2005 | CA2550123A1 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 06/30/2005 | CA2549741A1 Reagent for detecting an analyte |
| 06/30/2005 | CA2549457A1 Di (l) - lysine monosulfate trihydrate crystal and method of making |
| 06/29/2005 | EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | EP1546085A2 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 06/29/2005 | EP1545491A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 06/29/2005 | EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/29/2005 | CN1633473A Azo dyestuffs |
| 06/29/2005 | CN1631875A Synthesis method of L-aspartic acid-beta-benzylester |
| 06/29/2005 | CN1631874A Synthesis method of organic acid selenium |
| 06/29/2005 | CN1631539A Amino acid salt ion liquid and its preparation |
| 06/29/2005 | CN1208311C Process for preparing alkylene diamine triacetic acid |
| 06/28/2005 | US6911470 Used in treatment of infection by retroviruses such as HIV (HTLV-III/LAV), which causes acquired immuno-deficiency syndrome (AIDS) |
| 06/23/2005 | WO2005037784A3 Crystalline form of gamma-aminobutyric acid analog |
| 06/23/2005 | WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators |
| 06/23/2005 | WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 06/23/2005 | WO2004087064A3 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137421 Method for making fluorine labled L-Dopa |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137246 Organic amine salts of glutamic acid derivatives and their application |
| 06/23/2005 | US20050137236 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 06/23/2005 | US20050132947 DiL-lysine monosulfate trihydrate crystal and method of making |
| 06/22/2005 | EP1543214A2 Non-corrosive amphoteric surfactants and method of well treatment |
| 06/22/2005 | EP1175392B1 Contrast media |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1629207A Methods of synthesis of polysuccinimide, copolymers of polysuccinimide and derivatives thereof |
| 06/22/2005 | CN1629206A Methods of synthesis of polysuccinimide, copolymers of polysuccinimide and derivatives thereof |